Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes

doi:10.4239/wjd.v9.i12.252

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9430)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

762

WORD

236

HTML

6194

Tables (1-3)

149

Sum=7341

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

945

Download

1144

Sum=2089

Dec 15, 2018 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Dec 15, 2018; 9(12): 252-257
Published online Dec 15, 2018. doi: 10.4239/wjd.v9.i12.252

Table 3 Data density in the two comparator cohorts

	SGLT2	Control
Total facts	54852092	261813664
Avg facts per patient	1143	1325
Avg diagnosis facts per patient	231	262
Eastern United States, patients (%)	68	69
Western United States, patients (%)	32	31

SGLT2: Sodium-glucose co-transporter-2; Avg: Average.

Citation: Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes 2018; 9(12): 252-257
URL: https://www.wjgnet.com/1948-9358/full/v9/i12/252.htm
DOI: https://dx.doi.org/10.4239/wjd.v9.i12.252